Broad-Spectrum Antivirals and Interaction with Viruses
A special issue of Viruses (ISSN 1999-4915). This special issue belongs to the section "Viral Immunology, Vaccines, and Antivirals".
Deadline for manuscript submissions: 30 April 2024 | Viewed by 7526
Special Issue Editors
Interests: DNA repair; DNA damage response; genetics; primary immunodeficiency; B lymphocyte development; mouse models
Special Issues, Collections and Topics in MDPI journals
Interests: microbiota; immune system; transcriptiome; experimental pathology; metagenomics; intestinal microbiome; diabetes; COVID-19
Special Issue Information
Dear Colleagues,
A recently released database summarizes the activity of over 500 antivirus combinations along with their development status, as well as the antiviral activities of over 100 investigational and approved broad-spectrum antiviral drugs (BSAs) safe for humans (https://drugvirus.info/). Many drugs and drug combinations have shown new activities against SARS-CoV-2 and other viruses in preclinical (in vitro, in vivo) and clinical trials.
We invite submissions to expand these databases to include host-virus interaction, experimental antiviral drugs, new investigational and approved BSAs, and new antiviral combinations, including information on their development status and targets. Such contributions will improve our understanding of the general principles of virus-cell interaction and virus inhibition.
Dr. Valentyn Oksenych
Prof. Dr. Aleksandr Kamyshnyi
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antiviral combinations
- antiviral drug development
- broad-spectrum antivirals
- virus–host interaction